Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

2,310.00p
   
  • Change Today:
    -10.00p
  • 52 Week High: 3,170.00p
  • 52 Week Low: 1,924.00p
  • Currency: UK Pounds
  • Shares Issued: 66.54m
  • Volume: 173,420
  • Market Cap: £1,537.06m
  • RiskGrade: 128
  • Beta: 0.01

Latest ShareCast News

Genus shares slide on record profit as investors lock in gains

By Josh White

Date: Thursday 26 Feb 2026

(Sharecast News) - Genus reported record first-half adjusted operating profit and substantial strategic progress on Thursday, with strong growth in its porcine genetics division and improved profitability in bovine genetics, as the group reiterated full-year expectations following the formation of a Chinese joint venture, although shares fell sharply as investors locked in gains after a strong recent run.

Genus hails successful formation of Chinese porcine JV

By Michele Maatouk

Date: Monday 02 Feb 2026

(Sharecast News) - Animal genetics firm Genus said on Monday that it successfully formed its Chinese porcine joint venture on 31 January.

Berenberg lifts Genus forecasts, remains bullish for year ahead

By Benjamin Chiou

Date: Friday 16 Jan 2026

(Sharecast News) - Berenberg has raised its target price for Genus following the animal genetics group's first-half trading update on Friday, keeping the stock at a 'buy' citing "multiple catalysts" for the year ahead.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Genus Market Data

Currency UK Pounds
Share Price 2,310.00p
Change Today -10.00p
% Change -0.43 %
52 Week High 3,170.00p
52 Week Low 1,924.00p
Volume 173,420
Shares Issued 66.54m
Market Cap £1,537.06m
Beta 0.01
RiskGrade 128

Genus Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
92.49% below the market average92.49% below the market average92.49% below the market average92.49% below the market average92.49% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
78.22% above the market average78.22% above the market average78.22% above the market average78.22% above the market average78.22% above the market average
90.91% above the sector average90.91% above the sector average90.91% above the sector average90.91% above the sector average90.91% above the sector average
Income
98.6% below the market average98.6% below the market average98.6% below the market average98.6% below the market average98.6% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Growth
91.76% below the market average91.76% below the market average91.76% below the market average91.76% below the market average91.76% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

What The Brokers Say

Strong Buy 6
Buy 2
Neutral 2
Sell 0
Strong Sell 0
Total 10
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Genus Dividends

  Latest Previous
  Interim Final
Ex-Div 05-Mar-26 06-Nov-25
Paid 27-Mar-26 05-Dec-25
Amount 11.20p 21.70p

Trades for 11-May-2026

Time Volume / Share Price
16:50 18 @ 2,310.00p
16:47 872 @ 2,328.59p
16:42 100 @ 2,290.00p
16:37 6,309 @ 2,310.00p
16:37 6,309 @ 2,310.00p

Genus Key Personnel

CEO Jorgen Kokke
CFO Andy Russell

Top of Page